GL1X · GenesisL1 explorer

MolNFT v1 · #151847 · protein

Human JAK1 in complex with LASW1393

6HZU · Tyrosine-protein kinase JAK1: “Human JAK1 in complex with LASW1393”. X-ray diffraction, 1 ligand (GYQ), 6 pockets (best druggability 0.67). MolNFT v1 #151847 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6HZU
Type
protein
Length
579 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase JAK1
EC
2.7.10.2
UniProt
P23458
Ligands
GYQ
Pockets
6 · best druggability 0.67

Structure

x-ray diffraction · 2 distinct chains · 41% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase JAK1 (EC 2.7.10.2)protein29440% helix, 20% strandP23458
BTyrosine-protein kinase JAK1 (EC 2.7.10.2)protein28541% helix, 21% strandP23458

Ligands and binding sites

  • GYQ · 2-[4-[8-oxidanylidene-2-[(~{E})-(2-oxidanylidenepyridin-3-ylidene)amino]-7~{H}-purin-9-yl]cyclohexyl]ethanenitrile · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11960.670.8631GYQ
22000.640.8429GYQ
3930.510.8325empty
41090.490.8125empty
51270.420.7623empty

Interfaces

1 interface between chains.

  • A–B · 937 Ų buried · 15 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 modified (phosphorylation).

Compared structures

  • 6HZU · Human JAK1 in complex with LASW1393 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.